<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02455193</url>
  </required_header>
  <id_info>
    <org_study_id>14-1282</org_study_id>
    <secondary_id>UL1TR001082</secondary_id>
    <secondary_id>R01MH102224</secondary_id>
    <nct_id>NCT02455193</nct_id>
  </id_info>
  <brief_title>Neuronal Effects of Exercise in Schizophrenia</brief_title>
  <official_title>Neuronal Effects of Exercise in Schizophrenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study plans to learn more about how common drugs prescribed to individuals with
      schizophrenia contribute to weight gain, as well as how exercise and diet impact appetite and
      the brain's response to food. In this study, the investigators will be evaluating how
      patients' brains respond to food images as well as asking questions about their food
      preferences and intake and clinical symptoms. The investigators may also ask patients to
      complete an exercise or diet intervention to see how this changes brain responses or food
      preferences.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuronal response to visual food cues</measure>
    <time_frame>14 weeks</time_frame>
    <description>Neuronal response (insula) while viewing visual food cues</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Resting-state neuronal response</measure>
    <time_frame>14 weeks</time_frame>
    <description>Neuronal response (default mode network) during rest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Appetite Rating on a visual analogue scale (VAS)</measure>
    <time_frame>14 weeks</time_frame>
    <description>Participants will be asked to rate their hunger via Hunger ratings on a VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting leptin</measure>
    <time_frame>14 weeks</time_frame>
    <description>Fasting blood levels of leptin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting ghrelin</measure>
    <time_frame>14 weeks</time_frame>
    <description>Fasting blood levels of ghrelin</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Exercise intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 weeks of a moderate exercise intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 weeks of a diet intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <arm_group_label>Exercise intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet</intervention_name>
    <arm_group_label>Diet intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of schizophrenia or schizoaffective disorder

          -  Between 21 and 70 years of age

          -  Currently prescribed either olanzapine, risperidone, clozapine, or haloperidol, OR not
             currently being treated with any neuroleptic medications

          -  Weight stable within 5% for the last 6 months

        Exclusion Criteria:

          -  Pregnancy

          -  Substance abuse

          -  Significant endocrine/metabolic disease (e.g., uncontrolled hypertension, severe
             hypertriglyceridemia)

          -  MRI-specific exclusion criteria (e.g., claustrophobia, metal in the body)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason Tregellas, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristina T Legget, Ph.D.</last_name>
    <phone>303-724-5809</phone>
    <email>kristina.legget@ucdenver.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Anschutz Medical Campus</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina T Legget, PhD</last_name>
      <phone>303-724-5809</phone>
      <email>kristina.legget@ucdenver.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2015</study_first_submitted>
  <study_first_submitted_qc>May 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2015</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

